Condition: Head and Neck Squamous Cell Carcinoma · Sponsor: Tempus AI
The study is a prospective, longitudinal, non-interventional, multicenter study of participants with HNSCC who will have tissue and blood based molecular biomarker profiling during their standard of care treatment.
This description comes directly from the study's public registry record.
Phoenix HNSCC · (833) 514-4187 · phoenix@tempus.com
Always discuss trial participation with your own doctor first.
| City of Hope | Duarte, California, United States | Recruiting |
| USC/Norris Comprehensive Cancer Center | Los Angeles, California, United States | Recruiting |
| University of California, Los Angeles | Los Angeles, California, United States | Recruiting |
| Stanford | Palo Alto, California, United States | Recruiting |
| Providence Medical Foundation | Santa Rosa, California, United States | Recruiting |
| Morehouse | Atlanta, Georgia, United States | Recruiting |
| Piedmont Healthcare | Atlanta, Georgia, United States | Recruiting |
| Winship Cancer Institute, Emory University | Atlanta, Georgia, United States | Recruiting |
| Northwestern University Feinberg School of Medicine | Chicago, Illinois, United States | Recruiting |
| Cancer Care Specialists of Illinois | Decatur, Illinois, United States | Recruiting |
| Illinois Cancer Care | Peoria, Illinois, United States | Recruiting |
| University of Kansas | Westwood, Kansas, United States | Recruiting |
+ 18 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06163534